Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Vascular Stents Market by Application & Data Mining, Analysis and Forecast 2022

Tuesday, March 14, 2017 12:08
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Vascular Stents Market is accounted for $8.21 billion in 2015 and is expected to reach $11.6 billion by 2022 growing at a CAGR of 5.18% from 2015 to 2022. Growing recognition for vascular stents and increasing occurrence of cardiovascular diseases are the major factors driving the market growth. Moreover, growing number of aging population, increasing occurrence in peripheral diseases and improving new R&D devices and technologies are bolstering the growth of the market. However, huge capital for vascular stents and availability of different therapies are the major drawbacks in this market. On the other hand, increasing fondness for bioabsorbable stents will boost this market growth over the forecast period. Growing risk from substitutes and extreme competition are the major challenges involved.

Coronary Stents segment accounted for the largest share in this market due to growing number of aging population and accessibility of advanced treatments in this market. North America accounted for the largest market share during the forecast period owing to increased developments in technologies and important expenses of power in large segments. Moreover, Asia Pacific is the fastest promising market for global vascular stents market over the forecast period due to reduced cost of surgeries for healthcare treatments.

 

 For more information http://www.reportsweb.com/vascular-stents-global-market-outlook-2015-2022

 

Some of the key players in this market include Medtronic, Inc., Biosensors International Ltd., Abbott Laboratories, InnoCore Technologies BV, Stentys SA, MIV Therapeutics Inc., MicroPort Scientific Corp., X-Cell Medical Inc., InnoCore Technologies BV, Reva Medical Inc., Translumina GmbH, Boston Scientific Corporation, Goodman Co. Ltd., C.R.Bard Inc. and W.L. Gore & Associates. 

Products Covered
-Carotid Artery Stents
-Fem-pop Artery Stents
-Renal Artery Stents
-Iliac Artery Stents
-Infra-pop Stents
-Peripheral vascular stents
-Coronary stents
-Other Products

Materials Covered
-Metal stents
-Cobalt Alloys
-Absorbable Magnesium Alloys
-Nickel-Titanium Alloys
-Stainless Steel
-Standard polymeric stents
-Biodegradable polymeric stents

 

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322768/sample

 

10 Company Profiling 
10.1 Medtronic, Inc. 
10.2 Biosensors International Ltd. 
10.3 Abbott Laboratories 
10.4 InnoCore Technologies BV 
10.5 Stentys SA 
10.6 MIV Therapeutics Inc. 
10.7 MicroPort Scientific Corp. 
10.8 X-Cell Medical Inc. 
10.9 InnoCore Technologies BV 
10.10 Reva Medical Inc. 
10.11 Translumina GmbH 
10.12 Boston Scientific Corporation 
10.13 Goodman Co. Ltd. 
10.14 C.R.Bard Inc. 
10.15 W.L. Gore & Associates 

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322768/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.